News - Page 296

TLDR: Adcendo, a biotech company in Denmark, raised an additional €16M in Series A extension funding, bringing the total to €98M. The funding round was led by Dawn Biopharma and included participation

TLDR: Sequoia Capital has invested $1.5 billion in Walton Street India (WSIA) to accelerate innovation in the global financial services industry. This investment reflects Sequoia’s confidence in WSIA’s growth potential and aligns

TLDR: Mary Murtagh joins Silas Capital as Vice President on its investment team. Silas Capital focuses on investing in high-growth consumer brands. Silas Capital, an equity and venture capital firm, has announced

TLDR: – Catalyst Romania Fund I successfully exits SmartBill by selling its remaining shares to Visma, marking a successful exit for the portfolio. – SmartBill, a Romanian provider of cloud-based invoicing services,

TLDR: Identity.vc raises €15m to support LGBTQ+ founders in Europe. Co-founder Til Klein describes the fund as Europe’s first venture capital fund focused on early-stage LGBTQ+ led start-ups. The European venture capital

TLDR: CDP launches a second fund for development of financial infrastructures in venture capital market Fund will focus on investing in companies with high rate of innovation CDP Venture Capital has launched

TLDR: – Representatives of Korea’s top private equity firms met with UAE President Mohamed bin Zayed Al Nahyan. – The meeting sparked speculation over increased cooperation between the two countries on investment

TLDR: Clean Energy Ventures raises $305M Fund II to scale climate technologies Fund aims to mitigate 75 gigatons of emissions by 2050 Climate tech venture capital firm, Clean Energy Ventures, has closed

TLDR: Key Points: Clean Energy Ventures raised $305 million for its second fund to back early-stage climate startups. The fund was oversubscribed due to investor interest in emissions-reducing technologies. In a recent

TLDR: The article discusses the latest updates on the COVID-19 pandemic. Key points include the increased vaccine distribution, rising cases in certain regions, and new variants of the virus. The article provides